Oruka Therapeutics, Inc. (ORKA) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Oruka Therapeutics, Inc. in 2026. The next earnings report is expected on November 18, 2026.
Next earnings date
18 Nov 2026
In 90 days
EPS estimate
-0.58
Revenue estimate
0
Past earnings
Latest earnings analysis
Oruka Therapeutics missed consensus estimates in its latest report, with EPS of -$0.55 versus an expectation of -$0.5125 and revenue that met forecasts at $0. In the prior quarter, EPS came in ahead of expectations while revenue also met estimates.
No dividend history available.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Oruka Therapeutics, Inc. (ORKA) is scheduled to report earnings on November 18, 2026.
Oruka Therapeutics, Inc. (ORKA) last reported earnings on August 10, 2026.
Oruka Therapeutics, Inc. (ORKA) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.